Harvard Bioscience, Inc. (NASDAQ:HBIO) stock rose Friday after the company said it will reshape its production footprint across the U.S. and abroad.Harvard Bioscience aims to streamline operations and cut long-term costs.Facility ChangesThe company plans to close its Holliston, Massachusetts, plant. U.S. output will shift to its Minneapolis, Minnesota, hub. Some work will move to sites in Germany, Sweden, and the U.K.CEO John Duke said the reorganization builds on flexibility from recent refinancing. He sai ...